CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Want To Retire Early? Learn the Intelligent Investing Secret - October 28, 2019
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $65.70, moving -0.7% from the previous trading session.
Signs That Your Trading Will Ruin Your Retirement - October 15, 2019
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $62.99, marking a +0.08% move from the previous day.
Is CVS Health (CVS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Add Stryker (SYK) to Your Portfolio Now
by Zacks Equity Research
Stryker's (SYK) core Mako Platform has been consistently driving its top line.
Easy Investing Secrets to an Early Retirement - October 09, 2019
by Zacks Equity Research
Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.
Walgreens Inks Retail Health Collaboration Deal With Novant
by Zacks Equity Research
This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.
CVS Health (CVS) Stock Moves -0.4%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $61.99, moving -0.4% from the previous trading session.
Signs That Your Trading Will Ruin Your Retirement - October 07, 2019
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Health Insurers Hope to Gain From Executive Order on Medicare
by Sapna Bagaria
President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.
LabCorp to Expand Hematology Suite With Sysmex America Deal
by Zacks Equity Research
LabCorp (LH) will get to use Sysmex' advanced XN-9100 system, which is a scalable, modular automation system.
Walgreens (WBA) Becomes Latest Retailer to Suspend Zantac Sales
by Christopher Vargas
Walgreens (WBA) announced today that they would be suspending the sales of Sanofi's (SNY) heartburn medication Zantac.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.07, moving +1.59% from the previous trading session.
Rite Aid (RAD) Beats Q2 Earnings Estimates, Updates View
by Zacks Equity Research
Rite Aid (RAD) posts mixed second-quarter fiscal 2020 results. Further, management revises its view for the fiscal year.
Are Investors Undervaluing CVS Health (CVS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Opioid Overdose Crisis in US Likely to Affect These 3 Stocks
by Sreyoshi Mukherjee
Increasing lawsuits against pharmaceutical companies are likely to impact retailers and distributors.
Pharmacies & Drug Stores Industry Boasts Bright Prospects
by Urmimala Biswas
The Retail - Pharmacies and Drug Stores industry witnesses heavy consolidation.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $63.35, marking a -1.48% move from the previous day.
Cigna Expands Health Care Exchange Offerings to New Markets
by Zacks Equity Research
Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.47, moving +0.06% from the previous trading session.
Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy
by Zacks Equity Research
Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy
Should Invesco Russell 1000 Equal Weight ETF (EQAL) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EQAL
Here's How Cigna (CI) is Poised Amid Political Uncertainty
by Zacks Equity Research
Growth in health services, government business and international markets drive Cigna's (CI) stock.